This, the last of our posts on the 2018-19 New York State Health Budget (the “Enacted Budget”), focuses on an area of healthcare that has perhaps the broadest impact of the sector as a whole — managed care. ...more
Several provisions in the recently adopted 2018-19 New York State Budget (the “Enacted Budget”) are intended to address the ongoing opioid crisis. As discussed in a prior post, some were focused on pharmaceutical...more
4/9/2018
/ Drug & Alcohol Abuse ,
Drug Treatment ,
Healthcare Facilities ,
Mental Health ,
Opioid ,
Outpatient Services ,
Pain Management ,
Prescription Drugs ,
Regulatory Oversight ,
State and Local Government ,
State Budgets ,
State Funding ,
Substance Abuse
Notwithstanding the enactment of a first-in-the-nation drug spending cap last year, in light of the $4.4 billion deficit and ongoing concerns about the opioid crisis it was inevitable that this year New York State would once...more
4/5/2018
/ Drug Distribution ,
Drug Pricing ,
Generic Drugs ,
Opioid ,
Pain Management ,
Pharmaceutical Industry ,
Pharmacies ,
Prescription Drugs ,
Rebates ,
Regulatory Oversight ,
State and Local Government ,
State Budgets ,
State Medicaid Programs
In the wee hours of the morning on March 30, almost two days ahead of the April 1 deadline, the Legislature passed and the Governor signed a $168.3 billion State Budget for the 2018-19 fiscal year. ...more
4/3/2018
/ Federal Funding ,
Healthcare Facilities ,
Hospitals ,
Long-Term Care ,
Managed Care Contracts ,
Medicaid ,
Mental Health ,
New Legislation ,
Opioid ,
Pain Management ,
Pharmacies ,
State and Local Government ,
State Budgets